Of the cytokines participating in the cancer process, interleukin 6 (IL-6) has been shown to promote breast cancer metastasis [16–18], and high IL-6 levels are associated with poor clinical outcomes in breast tumors [19]. This evidence concerns the gene IL6 and cancer.